Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
Although the incidence of new cases of human immunodeficiency virus (HIV) has decreased in the past decade, in 2018 more than 7000 women with HIV were diagnosed in the United States (US). Globally, per recent reports, 48% of the new HIV infections were among women. There is still no vaccine to preve...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-06-01
|
| Series: | Women |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4184/1/2/11 |
| _version_ | 1827686293288517632 |
|---|---|
| author | Alina Cernasev Crystal Walker Drew Armstrong Jay Golden |
| author_facet | Alina Cernasev Crystal Walker Drew Armstrong Jay Golden |
| author_sort | Alina Cernasev |
| collection | DOAJ |
| description | Although the incidence of new cases of human immunodeficiency virus (HIV) has decreased in the past decade, in 2018 more than 7000 women with HIV were diagnosed in the United States (US). Globally, per recent reports, 48% of the new HIV infections were among women. There is still no vaccine to prevent HIV transmission. However, pre-exposure prophylaxis (PrEP) was approved in 2012 by the Food and Drug Administration, providing a powerful tool to block HIV infection and help prevent the subsequent development of acquired immunodeficiency syndrome (AIDS). The uptake of PrEP has been slow globally and among the most vulnerable populations in the US, even though the Centers for Disease Control (CDC) recommended its use in high-risk populations, including women. Furthermore, women represent one-quarter of people living with HIV in the US; however, PrEP is underutilized in this group. Thus, it is imperative to make women’s voices heard through conducting more research, ensuring sufficient access to PrEP, and enhancing knowledge about PrEP as a viable prevention strategy for women. This article aims to promote women’s health by changing the narrative, providing key information on empowering women, and increasing the usage of PrEP. |
| first_indexed | 2024-03-10T09:06:14Z |
| format | Article |
| id | doaj.art-5d54d03a55204322ab78fd768dac3858 |
| institution | Directory Open Access Journal |
| issn | 2673-4184 |
| language | English |
| last_indexed | 2024-03-10T09:06:14Z |
| publishDate | 2021-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Women |
| spelling | doaj.art-5d54d03a55204322ab78fd768dac38582023-11-22T06:21:01ZengMDPI AGWomen2673-41842021-06-011212012710.3390/women1020011Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among WomenAlina Cernasev0Crystal Walker1Drew Armstrong2Jay Golden3Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, 301 S. Perimeter Park Dr., Suite 220, Nashville, TN 37211, USADepartment of Health Promotion and Disease Prevention, University of Tennessee Health Science Center College of Nursing, 874 Union Avenue, Suite 301, Memphis, TN 38103, USADepartment of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USAWalgreens Specialty Pharmacy, 309 22nd Ave. N., Ste. C, Nashville, TN 37203, USAAlthough the incidence of new cases of human immunodeficiency virus (HIV) has decreased in the past decade, in 2018 more than 7000 women with HIV were diagnosed in the United States (US). Globally, per recent reports, 48% of the new HIV infections were among women. There is still no vaccine to prevent HIV transmission. However, pre-exposure prophylaxis (PrEP) was approved in 2012 by the Food and Drug Administration, providing a powerful tool to block HIV infection and help prevent the subsequent development of acquired immunodeficiency syndrome (AIDS). The uptake of PrEP has been slow globally and among the most vulnerable populations in the US, even though the Centers for Disease Control (CDC) recommended its use in high-risk populations, including women. Furthermore, women represent one-quarter of people living with HIV in the US; however, PrEP is underutilized in this group. Thus, it is imperative to make women’s voices heard through conducting more research, ensuring sufficient access to PrEP, and enhancing knowledge about PrEP as a viable prevention strategy for women. This article aims to promote women’s health by changing the narrative, providing key information on empowering women, and increasing the usage of PrEP.https://www.mdpi.com/2673-4184/1/2/11PrEPtruvada for PrEPwomenHIV-negative |
| spellingShingle | Alina Cernasev Crystal Walker Drew Armstrong Jay Golden Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women Women PrEP truvada for PrEP women HIV-negative |
| title | Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women |
| title_full | Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women |
| title_fullStr | Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women |
| title_full_unstemmed | Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women |
| title_short | Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women |
| title_sort | changing the prep narrative a call to action to increase prep uptake among women |
| topic | PrEP truvada for PrEP women HIV-negative |
| url | https://www.mdpi.com/2673-4184/1/2/11 |
| work_keys_str_mv | AT alinacernasev changingtheprepnarrativeacalltoactiontoincreaseprepuptakeamongwomen AT crystalwalker changingtheprepnarrativeacalltoactiontoincreaseprepuptakeamongwomen AT drewarmstrong changingtheprepnarrativeacalltoactiontoincreaseprepuptakeamongwomen AT jaygolden changingtheprepnarrativeacalltoactiontoincreaseprepuptakeamongwomen |